Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

FDMTFDMT
22 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in 4D MOLECULAR THERAPEUTICS IN

NORTHERN TRUST CORP holds 562,929 shares of FDMT (4D MOLECULAR THERAPEUTICS IN), worth $7.5M as of 2026-Q2. The position was increased (+64.6% shares). FDMT represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$7.5M

Current Shares

562,929

Total Value Change

+$3.7M

Total Shares Change

+475,786

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
562,929
+64.6%
$7.5M0.0%$13.30
40
2026-Q1
Increased
342,034
+9.0%
$3.2M0.0%$8.46
29
2025-Q4
Decreased
313,820
-6.5%
$2.4M0.0%$7.58
0
2025-Q3
Increased
335,586
+2.0%
$2.9M0.0%$8.35
27
2025-Q2
Decreased
328,975
-13.6%
$1.2M0.0%$3.84
0
2025-Q1
Decreased
380,920
-13.6%
$1.2M0.0%$3.63
0
2024-Q4
Increased
440,665
+2.3%
$2.5M0.0%$5.30
27
2024-Q3
Increased
430,683
+17.2%
$4.7M0.0%$10.83
31
2024-Q2
Decreased
367,479
-1.8%
$7.7M0.0%$20.99
0
2024-Q1
Increased
374,182
+2.4%
$11.9M0.0%$31.86
29
2023-Q4
Increased
365,343
+0.4%
$7.4M0.0%$20.26
27
2023-Q3
Increased
363,725
+9.4%
$4.6M0.0%$12.73
29
2023-Q2
Increased
332,367
+21.1%
$6M0.0%$17.73
32
2023-Q1
Decreased
274,429
-0.1%
$4.7M0.0%$16.75
0
2022-Q4
Decreased
274,821
-0.7%
$6.1M0.0%$22.21
0
2022-Q3
Increased
276,680
+0.9%
$2.2M0.0%$8.22
26
2022-Q2
Increased
274,331
+5.8%
$1.9M0.0%$7.27
27
2022-Q1
Increased
259,280
+1.9%
$3.9M0.0%$15.49
27
2021-Q4
Increased
254,372
+34.0%
$5.6M0.0%$21.87
35
2021-Q3
Increased
189,825
+92.7%
$5.1M0.0%$27.92
43
2021-Q2
Increased
98,528
+13.1%
$2.4M0.0%$23.50
29
2021-Q1
New
87,143
-
$3.8M0.0%$38.55
37

Other major holders of FDMT: VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used